Photoacoustic tomography for assessment and quantification of cutaneous and metastatic malignant melanoma - A systematic review

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Background: Photoacoustic tomography (PAT) is an emerging noninvasive imaging technique combining high sensitivity optical absorption contrast, such as melanin, with high-resolution ultrasound for deep tissue imaging. The ability of PAT to provide real-time images of skin structures at depth has been studied for diagnosis of primary and metastatic malignant melanoma (MM). Objective: To provide an overview of the rapidly expanding clinical use of PAT for determination of melanoma thickness and architecture, visualization of metastases in lymph nodes and detection of circulating melanoma cells. Methods: Medline, PubMed, EMBASE, Web of Science, Google Scholar, and Cochrane Library were searched for papers using PAT to assess cutaneous malignant melanoma and melanoma metastases in humans or human specimens. Results: The research resulted in 14 articles which met the search criteria. Conclusions: Results from current studies suggest that PAT is a promising tool for assessing both primary and metastatic malignant melanoma in the clinic. The potential of PAT to noninvasively visualize tumour boundaries, as well as assist in the evaluation of metastatic status, could facilitate more effective treatment, resulting in better clearance and reducing the need for additional biopsies. However, larger and methodologically sound studies are warranted.

OriginalsprogEngelsk
Artikelnummer102095
TidsskriftPhotodiagnosis and Photodynamic Therapy
Vol/bind33
ISSN1572-1000
DOI
StatusUdgivet - 2021

Bibliografisk note

Funding Information:
The MSOT system utilized to record image in Fig. 1 was granted by The Vissing Foundation , Denmark, the Doppler ultrasound system was donated by Abbvie, Denmark and Mette Mogensen’s salary is partly funded by the Research Foundation of Bispebjerg and Frederiksberg Hospital , Denmark.

Publisher Copyright:
© 2020 Elsevier B.V.

ID: 303046459